
Laboratory of Metabolism, Nutrition and Atherosclerosis - University of Pisa. Clinical & experimental study of #diabetes #nutrition and #cardiovasculardisease
Joined September 2022
- Tweets67
- Following53
- Followers41
- Likes50
Una settimana fa si è concluso il congresso nazionale della SID! @Sid_Italia
Il gruppo del MetaLab ha portato a casa altri due riconoscimenti:
La dottoressa @MartinaChiriac3 e la dottoressa @noemicimb sono state premiate per la migliore Comunicazione Orale! Congratulazioni!
Grande partecipazione del #MetaLab al Congresso @Sid_Italia! Orgogliosi di aver portato il nostro contributo scientifico alla prestigiosa platea dei soci SID. Grazie a tutto il team per l’impegno e la passione.
Congratulazioni al dr. Luca Sacchetta @LucaSacchetta94, che in questi giorni è stato insignito del Premio Renzo Navalesi da parte della Società Italiana di Diabetologia @Sid_Italia. Un riconoscimento che premia la qualità e la passione del suo lavoro. #SID #ricerca #Metalab
2
39
Una partenza grandiosa per il MetaLab team al 31esimo congresso nazionale della @Sid_Italia @dotLorenzoNesti @Ceci_Morgantini #andreanatali #sid
5
70
Congratulations to our researcher, Dr. @MartinaChiriac3, on successfully defending her PhD thesis! 🎓
This important milestone reflects years of dedication, passion, and outstanding research. We are proud and honored to celebrate this achievement with you! 👏🏻
@SantAnnaPisa
Why does the liver accumulate fat in the early stages of MASLD? Our latest study reveals a major, often overlooked player: the small intestine. 🧵👇
A striking 52% rise in oral glucose absorption is seen in #MASLD, spotlighting the gut–liver axis as a potential early driver of disease @MetaLab_Unipi link.springer.com/article/10… 🔓
META Lab_Unipi retweeted
A striking 52% rise in oral glucose absorption is seen in #MASLD, spotlighting the gut–liver axis as a potential early driver of disease @MetaLab_Unipi link.springer.com/article/10… 🔓
The 2nd EASD Diabetes #Technology School 2026 has ended.🎓
Thank you to all participants and to our fantastic faculty, @JuliaMader, @PratikChoudhary, @PieterGillard & @JuliaWare for making Vienna a stimulating experience for the #diabetes community.
Until next time!👏

ALT Group photo of approximately 60 participants and faculty at the 2nd EASD Diabetes Technology School, held 16-18 April 2026 in Vienna, Austria. Attendees wearing orange lanyards are gathered in a modern conference room, with a large screen in the background displaying, "Welcome to the 2nd EASD Diabetes Technology School" the event's welcome slide.
Warmest wishes from the MetaLab at the University of Pisa 🎉
From our team of researchers, we send our very best wishes for success, inspiration, and new discoveries ahead.
#MetaLab #UniversityOfPisa
1
45
META Lab_Unipi retweeted
Happening now in Düsseldorf! 🚀
Great start of our meeting with Prof. Roden’s opening lecture on precision diabetology, followed by talks on prevention & diabetes heterogeneity. Fantastic energy & networking!🤝
Thanks to the DDZ for hosting, excited for what’s ahead!
#Diabetes
Celebrating 2026 achievements!
Our talented young researchers @SantoniLorenza and @LucaSacchetta94 have successfully completed their residency and are now proud specialists in Internal Medicine.
3
51
META Lab_Unipi retweeted
Reduced sodium intake is associated with a higher risk of heart failure and cardiovascular death but this excess risk is attenuated by canagliflozin #type2diabetes #heartfailure #SGLT2inhibitors @MartinaChiriac3 @MetaLab_Unipi link.springer.com/article/10…
META Lab_Unipi retweeted
Salt sensitivity of #bloodpressure: are SGLT2 inhibitors the new heroes?
Find out how #SGLT2i reduce the hypertensive response to high #sodium in type 2 diabetes 🧂🧂🧂
Look up our new paper in Cardiovascular Diabetolgy ➡️ @MetaLab_Unipi @BioMedCentral
doi.org/10.1186/s12933-026-0…
META Lab_Unipi retweeted
🚀 GLP-1 medicines have revolutionized the treatment of type 2 diabetes and obesity.
⚖️ However, there is tremendous heterogeneity in response to treatment and significant unmet need exists.
📊 42.9% of those with type 2 diabetes failed to have clinically meaningful improvement in glycemic control or body weight, according to a real world study of European adults with type 2 diabetes
❗📉 Only 14% achieved meaningful reductions in BOTH a1c and body weight.
pmc.ncbi.nlm.nih.gov/article…
Our one and only Prof. Domenico Tricò @DomenTrico, our wild card during the last @EASDnews Annual Meeting, member of the @EASDacademy Committee, serving:
-Oral presentations
-Moderations
-Interviews
-Lectures
-And more!
Memories from the last EASD annual meeting: Dr. Simone Gallo on stage, talking about Diabetes complications and how to predict their development.
@EASDnews @Sid_Italia
5
77
We have a Queen, but also a C-PET King! 👑 Dr. @dotLorenzoNesti presented the results of his work on #HFpEF at 61th @EASDnews Annual Meeting in Vienna.
Our Cardiopulmonary Exercise Testing Queen 👑 dr. @SantoniLorenza presenting her work at 61th @EASDnews Annual Meeting in Vienna.
Congrats to our Dr. Noemi Cimbalo for winning the Early Career Academy Best Abstract Award at 61th @EASDnews!
A huge emotion for all the Meta Lab Team! 🏆 @noemicimb
Lights on Dr. Chiriacò, who presented the results of the patient-level analysis of CANVAS and CREDENCE trials at 61th EASD Annual Meeting in Vienna!
@MartinaChiriac3 @EASDnews #EASD2025















































